Health systems have been forced to delay care and forgo revenue as they manage device and drug shortages.
More than half of 102 hospitals, health systems and suppliers surveyed had to cancel or reschedule procedures multiple times last year due to product shortages, according to a poll conducted this spring by Premier, a consulting and group purchasing organization. Syringes, IV fluids, saline, aortic balloon catheters and surgical tourniquets are in short supply, providers said.
Related: What Biden's tariffs on Chinese medical supplies mean for industry
Health systems and suppliers expect shortages to impede operations amid inflation, geopolitical tension and labor constraints. In response, providers plan to broaden their supplier networks, work with more U.S.-based manufacturers and automate supply chain technology.
Here are five takeaways from the survey.
1. Supply chain challenges may worsen
Nearly 80% of providers expect supply chain issues to remain the same or worsen over the next year, up from 75% in last year’s survey.
The Israel-Hamas and Russia-Ukraine wars, new tariffs on medical products from China, and natural disasters have strained the supply of devices and drugs, as well as the raw materials used to make them, respondents said.
Inflation, backorders and higher labor costs were also among providers’ top concerns.
“Inflation in the form of higher energy, labor, materials, transport and logistics costs continues to be persistent,” said Kyle MacKinnon, senior director of operational excellence at Premier. “Providers are looking at ways to mitigate those pressures by leveraging technology, such as through predictive analytics and demand forecasting.”
2. Shortages disrupt care plans
More than 51% of providers canceled or rescheduled procedures multiple times last year due to shortages. Of that share, 15% reported weekly disruptions.
Roughly two-thirds of respondents said their teams were spending at least 10 hours per week mitigating supply chain shortages.